A synergic role of caspase-6 and caspase-3 in tau truncation at D421 induced by H2O2

Cellular and Molecular Neurobiology

Volumn 34, Issue 3, 2014, Pages 369-378

  Zhao, Hong ^a   Zhao, Wenjuan ^a   Lok, Kenghoe ^a   Wang, Zejian ^a   Yin, Ming ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Caspase 3; Caspase 6; HEK 293 tau cells; Tau truncation

Indexed keywords

ACETYLCYSTEINE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 6; HYDROGEN PEROXIDE; LIPOFECTAMINE; TAU PROTEIN; ASPARTIC ACID; ENZYME INHIBITOR;

ARTICLE; CELL DAMAGE; CELL STRAIN HEK293; CELL VIABILITY; CYTOTOXICITY; DOSE RESPONSE; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSIENT EXPRESSION; CELL SURVIVAL; DRUG EFFECTS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY;

ASPARTIC ACID; CASPASE 3; CASPASE 6; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; TAU PROTEINS;

EID: 84896488682     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-013-0021-x     Document Type: Article

References (37)

1. Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC (2007) Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 170(4):1200-1209 (Pubitemid 47339328)
2. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22(21):9340-9351
3. Allsopp TE, McLuckie J, Kerr LE, Macleod M, Sharkey J, Kelly JS (2000) Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ 7(10):984-993
4. Basurto-Islas G, Luna-Munoz J, Guillozet-Bongaarts AL, Binder LI, Mena R, Garcia-Sierra F (2008) Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 67(5):470-483 (Pubitemid 351653539)
5. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33(1):95-130
6. Cao XH, Wang AH, Wang CL, Mao DZ, Lu MF, Cui YQ, Jiao RZ (2010) Surfactin induces apoptosis in human breast cancer MCF- 7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem Biol Interact 183(3):357-362
7. Chen S, Ge X, Chen Y, Lv N, Liu Z, Yuan W (2013) Advances with RNA interference in Alzheimer's disease research. Drug Des Devel Ther 7:117-125
8. Chuang CY, Chen TL, Cherng YG, Tai YT, Chen TG, Chen RM (2011) Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway. Arch Toxicol 85(3):209-218
9. Cotman CW, Poon WW, Rissman RA, Blurton-Jones M (2005) The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol 64(2):104-112 (Pubitemid 40349308)
10. 2. J Neurochem 126(2):234-242
11. Ferrer I, Lopez E, Blanco R, Rivera R, Krupinski J, Marti E (2000) Differential c-Fos and caspase expression following kainic acid excitotoxicity. Acta Neuropathol 99(3):245-256 (Pubitemid 30099173)
12. Filipcik P, Cente M, Krajciova G, Vanicky I, Novak M (2009) Cortical and hippocampal neurons from truncated tau transgenic rat express multiple markers of neurodegeneration. Cell Mol Neurobiol 29(6-7):895-900
13. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 100(17):10032-10037 (Pubitemid 37087063)
14. Garcia-Sierra F, Mondragon-Rodriguez S, Basurto-Islas G (2008) Truncation of tau protein and its pathological significance in Alzheimer's disease. J Alzheimers Dis 14(4):401-409
15. Graham RK, Ehrnhoefer DE, Hayden MR (2011) Caspase-6 and neurodegeneration. Trends Neurosci 34(12):646-656
16. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83(13):4913-4917
17. Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI (2005) Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol Aging 26(7):1015-1022 (Pubitemid 40312665)
18. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC (2004) Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 165(2):523-531 (Pubitemid 38971382)
19. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer's disease. Lancet 2(8504): 421-426 (Pubitemid 16047953)
20. 2 and caspases 3 and 6 in the absence of cell death. Int J Biochem Cell Biol 41(4):945-956
21. Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci USA 83(11):4044-4048 (Pubitemid 16062419)
22. Kumar AP, Chang MK, Fliegel L, Pervaiz S, Clement MV (2007) Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity. Cell Death Differ 14(10):1733-1746 (Pubitemid 47423641)
23. LeBlanc AC (2013) Caspase-6 as a novel early target in the treatment of Alzheimer's disease. Eur J Neurosci 37(12):2005-2018
24. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251(4994):675-678 (Pubitemid 21916893)
25. Liu X, Kim CN, Pohl J, Wang X (1996) Purification and characterization of an interleukin-1beta-converting enzyme family protease that activates cysteine protease P32 (CPP32). J Biol Chem 271(23):13371-13376 (Pubitemid 26185376)
26. Milton NG (2004) Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. Drugs Aging 21(2):81-100
27. Novak M, Kabat J, Wischik CM (1993) Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J 12(1):365-370 (Pubitemid 23042416)
28. Pop C, Salvesen GS (2009) Human caspases: activation, specificity, and regulation. J Biol Chem 284(33):21777-21781
29. Quintanilla RA, Dolan PJ, Jin YN, Johnson GV (2012) Truncated tau and Abeta cooperatively impair mitochondria in primary neurons. Neurobiol Aging 33(3):619-635
30. Ramcharitar J, Albrecht S, Afonso VM, Kaushal V, Bennett DA, Leblanc AC (2013) Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol 72(9):824-832
31. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114(1):121-130 (Pubitemid 39071651)
32. Shimohama S, Tanino H, Fujimoto S (2001) Differential expression of rat brain caspase family proteins during development and aging. Biochem Biophys Res Commun 289(5):1063-1066 (Pubitemid 34076298)
33. Troy CM, Salvesen GS (2002) Caspases on the brain. J Neurosci Res 69(2):145-150 (Pubitemid 34734145)
34. Vina J, Lloret A, Orti R, Alonso D (2004) Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress. Mol Aspects Med 25(1-2):117-123 (Pubitemid 38401936)
35. Xanthoudakis S, Roy S, Rasper D, Hennessey T, Aubin Y, Cassady R, Tawa P, Ruel R, Rosen A, Nicholson DW (1999) Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J 18(8):2049-2056 (Pubitemid 29179162)
36. Zhang Q, Zhang X, Chen J, Miao Y, Sun A (2009a) Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies. J Neurochem 109(2):476-484
37. Zhang Q, Zhang X, Sun A (2009b) Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models. Acta Neuropathol 117(6):687-697